PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2016

Apr 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2016-04-14

Reporting Person: ZAVRL FRANK (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-14	Stock Option (Right to Buy)	$31.95	A	10000	Acquired	2026-04-13	Common Stock (10000)	Direct

Footnotes

F1: The vesting commencement date ("VCD") of the option is April 14, 2016. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the VCD and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the VCD thereafter, subject to the Reporting Person's continued service through each vesting date as a member of the Compensation Committee of the Board of Directors of the Issuer.